Table 2. In vivo efficacy of mAbP for post-exposure prophylaxis of hamster injected with a lethal dose of coyote rabies street viruses
Post-exposure treatment
Vaccine (HDCV)*
Antibody (units per animal) - +
mAbP (3) 5/9 9/9
mAbP (0.7) 1/9 8/9
mAbP (0.4) 2/9 8/9
HRIG (2) 4/9 8/9
Untreated control 0/9 0/3
  • Data are of surviving hamsters/number of hamsters tested

  • * HDCV, commercial (Imovax, lot MO475) human diploid cell culture rabies virus vaccine. - and +, treatments without or with HDCV, respectively